{
  "buckets": {
    "module": {
      "900000000000207008": 17
    },
    "semanticTags": {
      "disorder": 8,
      "procedure": 2
    },
    "language": {
      "en": 17
    },
    "membership": {
      "1322291000000109": 10,
      "1127601000000107": 8,
      "1382531000000102": 7,
      "2181181000000106": 1,
      "999003161000000108": 1,
      "900000000000497000": 10,
      "733073007": 10,
      "999002271000000101": 9,
      "999001061000000106": 1
    }
  },
  "languageNames": {
    "en": "english"
  },
  "bucketConcepts": {
    "1322291000000109": {
      "conceptId": "1322291000000109",
      "active": true,
      "definitionStatus": "PRIMITIVE",
      "moduleId": "999000041000000102",
      "fsn": {
        "term": "National Health Service Care Record Element association reference set (foundation metadata concept)",
        "lang": "en"
      },
      "pt": {
        "term": "NHS Care Record Element association reference set",
        "lang": "en"
      },
      "id": "1322291000000109"
    },
    "1127601000000107": {
      "conceptId": "1127601000000107",
      "active": true,
      "definitionStatus": "PRIMITIVE",
      "moduleId": "999000021000000109",
      "fsn": {
        "term": "Healthcare matters simple reference set (foundation metadata concept)",
        "lang": "en"
      },
      "pt": {
        "term": "Healthcare matters simple reference set",
        "lang": "en"
      },
      "id": "1127601000000107"
    },
    "1382531000000102": {
      "conceptId": "1382531000000102",
      "active": true,
      "definitionStatus": "PRIMITIVE",
      "moduleId": "999000021000000109",
      "fsn": {
        "term": "Emergency care diagnosis max simple reference set (foundation metadata concept)",
        "lang": "en"
      },
      "pt": {
        "term": "Emergency care diagnosis max simple reference set",
        "lang": "en"
      },
      "id": "1382531000000102"
    },
    "2181181000000106": {
      "conceptId": "2181181000000106",
      "active": true,
      "definitionStatus": "PRIMITIVE",
      "moduleId": "999000021000000109",
      "fsn": {
        "term": "Paediatric genitourinary and renal disorders simple reference set (foundation metadata concept)",
        "lang": "en"
      },
      "pt": {
        "term": "Paediatric genitourinary and renal disorders simple reference set",
        "lang": "en"
      },
      "id": "2181181000000106"
    },
    "999003161000000108": {
      "conceptId": "999003161000000108",
      "active": true,
      "definitionStatus": "PRIMITIVE",
      "moduleId": "999000021000000109",
      "fsn": {
        "term": "National Cancer Registration and Analysis Service histopathology reporting - CLUSTER 1A Malignant diagnosis simple reference set (foundation metadata concept)",
        "lang": "en"
      },
      "pt": {
        "term": "National Cancer Registration and Analysis Service histopathology reporting - CLUSTER 1A Malignant diagnosis simple reference set",
        "lang": "en"
      },
      "id": "999003161000000108"
    },
    "900000000000497000": {
      "conceptId": "900000000000497000",
      "active": true,
      "definitionStatus": "PRIMITIVE",
      "moduleId": "900000000000012004",
      "fsn": {
        "term": "CTV3 to SNOMED CT simple map reference set (foundation metadata concept)",
        "lang": "en"
      },
      "pt": {
        "term": "CTV3 to SNOMED CT simple map",
        "lang": "en"
      },
      "id": "900000000000497000"
    },
    "733073007": {
      "conceptId": "733073007",
      "active": true,
      "definitionStatus": "PRIMITIVE",
      "moduleId": "900000000000012004",
      "fsn": {
        "term": "OWL axiom reference set (foundation metadata concept)",
        "lang": "en"
      },
      "pt": {
        "term": "OWL axiom reference set",
        "lang": "en"
      },
      "id": "733073007"
    },
    "999002271000000101": {
      "conceptId": "999002271000000101",
      "active": true,
      "definitionStatus": "PRIMITIVE",
      "moduleId": "999000011000000103",
      "fsn": {
        "term": "International Classification of Diseases, Tenth Revision, Fifth Edition, five character code United Kingdom complex map reference set (foundation metadata concept)",
        "lang": "en"
      },
      "pt": {
        "term": "International Classification of Diseases, Tenth Revision, Fifth Edition, five character code United Kingdom complex map reference set",
        "lang": "en"
      },
      "id": "999002271000000101"
    },
    "999001061000000106": {
      "conceptId": "999001061000000106",
      "active": true,
      "definitionStatus": "PRIMITIVE",
      "moduleId": "999000021000000109",
      "fsn": {
        "term": "Renal clinical finding simple reference set (foundation metadata concept)",
        "lang": "en"
      },
      "pt": {
        "term": "Renal clinical finding simple reference set",
        "lang": "en"
      },
      "id": "999001061000000106"
    },
    "900000000000207008": {
      "conceptId": "900000000000207008",
      "active": true,
      "definitionStatus": "PRIMITIVE",
      "moduleId": "900000000000012004",
      "fsn": {
        "term": "SNOMED CT core module (core metadata concept)",
        "lang": "en"
      },
      "pt": {
        "term": "SNOMED CT core",
        "lang": "en"
      },
      "id": "900000000000207008"
    }
  },
  "totalElements": 17,
  "totalPages": 1,
  "last": true,
  "numberOfElements": 17,
  "first": true,
  "size": 50,
  "number": 0,
  "items": [
    {
      "term": "Treatment failure risk education",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "304532001",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Treatment failure risk education (procedure)",
          "lang": "en"
        },
        "pt": {
          "term": "Treatment failure risk education",
          "lang": "en"
        },
        "id": "304532001"
      }
    },
    {
      "term": "Advice about failure risk of treatment",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "304532001",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Treatment failure risk education (procedure)",
          "lang": "en"
        },
        "pt": {
          "term": "Treatment failure risk education",
          "lang": "en"
        },
        "id": "304532001"
      }
    },
    {
      "term": "Advice about failure risk of drug treatment",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "223419009",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Medication failure risk education (procedure)",
          "lang": "en"
        },
        "pt": {
          "term": "Medication failure risk education",
          "lang": "en"
        },
        "id": "223419009"
      }
    },
    {
      "term": "Treatment failure risk education (procedure)",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "304532001",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Treatment failure risk education (procedure)",
          "lang": "en"
        },
        "pt": {
          "term": "Treatment failure risk education",
          "lang": "en"
        },
        "id": "304532001"
      }
    },
    {
      "term": "A rare ophthalmic condition with characteristics of the formation of excessive scar tissue between the conjunctiva/Tenon capsule and the sclera at the surgical site following glaucoma filtration surgery. Scarring can occur months or years after surgery, resulting in treatment failure with poor postoperative control of intraocular pressure and potentially loss of vision.",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "1264000005",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Scar of eye due to and following filtration operation for glaucoma (disorder)",
          "lang": "en"
        },
        "pt": {
          "term": "Scar of eye due to and following filtration operation for glaucoma",
          "lang": "en"
        },
        "id": "1264000005"
      }
    },
    {
      "term": "A rare genetic parenchymatous liver disease with characteristics of infantile or early childhood onset of recurrent episodes of acute liver failure precipitated by a febrile illness. During the life-threatening episodes, patients present with vomiting, lethargy, jaundice as well as elevated levels of liver enzymes and coagulopathy. There is usually complete recovery between the episodes with conservative treatment.",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "1208726006",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Fever-associated acute infantile liver failure syndrome (disorder)",
          "lang": "en"
        },
        "pt": {
          "term": "Fever-associated acute infantile liver failure syndrome",
          "lang": "en"
        },
        "id": "1208726006"
      }
    },
    {
      "term": "A rare genetic odontologic disease with characteristics of failure of eruption of non-ankylosed permanent teeth without evidence of obvious mechanical obstruction. Posterior teeth are preferentially affected (typically with involvement of all teeth distal to the most mesial non-erupted tooth), resulting in a posterior open bite. Non-ankylosed teeth tend to become ankylosed, and orthodontic treatment of affected teeth is generally unsuccessful.",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "1231153007",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Primary failure of tooth eruption (disorder)",
          "lang": "en"
        },
        "pt": {
          "term": "Primary failure of tooth eruption",
          "lang": "en"
        },
        "id": "1231153007"
      }
    },
    {
      "term": "A rare mitochondrial disease due to a defect in mitochondrial protein synthesis with characteristics of neonatal or infancy-onset of seizures that are refractory to treatment, delayed or absent psychomotor development and lactic acidosis. Additional manifestations reported include poor feeding, failure to thrive, microcephaly, hypotonia, anemia and thrombocytopenia. Caused by homozygous or compound heterozygous mutation in the FARS2 gene on chromosome 6p25.",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "778065005",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Combined oxidative phosphorylation defect type 14 (disorder)",
          "lang": "en"
        },
        "pt": {
          "term": "Combined oxidative phosphorylation defect type 14",
          "lang": "en"
        },
        "id": "778065005"
      }
    },
    {
      "term": "A rare mitochondrial disease due to a defect in mitochondrial protein synthesis with characteristics of neonatal or infancy-onset of seizures that are refractory to treatment, delayed or absent psychomotor development and lactic acidosis. Additional manifestations reported include poor feeding, failure to thrive, microcephaly, hypotonia, anaemia and thrombocytopenia. Caused by homozygous or compound heterozygous mutation in the FARS2 gene on chromosome 6p25.",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "778065005",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Combined oxidative phosphorylation defect type 14 (disorder)",
          "lang": "en"
        },
        "pt": {
          "term": "Combined oxidative phosphorylation defect type 14",
          "lang": "en"
        },
        "id": "778065005"
      }
    },
    {
      "term": "A rare genetic erythrokeratoderma disorder characterized by generalized cutaneous erythema with fine white scales and pruritus refractory to treatment, progressive dilated cardiomyopathy, palmoplantar keratoderma, sparse or absent eyebrows and eyelashes, sparse scalp hair, nail dystrophy and dental enamel anomalies. Variable features include failure to thrive, developmental delay and development of corneal opacities. Histology shows psoriasiform acanthosis, hypogranulosis, and compact orthohyperkeratosis.",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "1179293006",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Erythrokeratodermia cardiomyopathy syndrome (disorder)",
          "lang": "en"
        },
        "pt": {
          "term": "Erythrokeratodermia cardiomyopathy syndrome",
          "lang": "en"
        },
        "id": "1179293006"
      }
    },
    {
      "term": "A rare genetic erythrokeratoderma disorder characterised by generalised cutaneous erythema with fine white scales and pruritus refractory to treatment, progressive dilated cardiomyopathy, palmoplantar keratoderma, sparse or absent eyebrows and eyelashes, sparse scalp hair, nail dystrophy and dental enamel anomalies. Variable features include failure to thrive, developmental delay and development of corneal opacities. Histology shows psoriasiform acanthosis, hypogranulosis, and compact orthohyperkeratosis.",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "1179293006",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Erythrokeratodermia cardiomyopathy syndrome (disorder)",
          "lang": "en"
        },
        "pt": {
          "term": "Erythrokeratodermia cardiomyopathy syndrome",
          "lang": "en"
        },
        "id": "1179293006"
      }
    },
    {
      "term": "A rare bone disease characterized by secondary hyperparathyroidism in patients with chronic renal failure, caused by improper treatment in the early stages of the disease with retention of phosphorus, vitamin D deficiency and disturbed calcium-phosphorus metabolism, which result in increased parathyroid hormone levels. Patients present with short stature, severe changes of the skull and jaws as well as other skeletal deformities, dental anomalies, brown tumors in the mouth, hearing loss, and neuropsychiatric disorders.",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "1208934006",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Sagliker syndrome (disorder)",
          "lang": "en"
        },
        "pt": {
          "term": "Sagliker syndrome",
          "lang": "en"
        },
        "id": "1208934006"
      }
    },
    {
      "term": "A rare bone disease characterised by secondary hyperparathyroidism in patients with chronic renal failure, caused by improper treatment in the early stages of the disease with retention of phosphorus, vitamin D deficiency and disturbed calcium-phosphorus metabolism, which result in increased parathyroid hormone levels. Patients present with short stature, severe changes of the skull and jaws as well as other skeletal deformities, dental anomalies, brown tumours in the mouth, hearing loss, and neuropsychiatric disorders.",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "1208934006",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Sagliker syndrome (disorder)",
          "lang": "en"
        },
        "pt": {
          "term": "Sagliker syndrome",
          "lang": "en"
        },
        "id": "1208934006"
      }
    },
    {
      "term": "A subgroup of therapy-related myeloid neoplasms (t-MN), associated with a treatment of an unrelated neoplastic or autoimmune disease with cytotoxic agents, like cyclophosphamid, platins, melphalan and others. The neoplastic cells typically harbor unbalanced aberrations of chromosomes 5 and 7 (monosomy 5/del(5q) and monosomy 7/del(7q)) or a complex karyotype. It usually presents with multilineage dysplasia and cytopenias 5-10 years after exposure, with symptoms related to the degree of bone marrow failure and the corresponding cytopenia (fatigue, bleeding and bruising, recurrent infections, bone pain).",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "766045006",
        "active": true,
        "definitionStatus": "FULLY_DEFINED",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent (disorder)",
          "lang": "en"
        },
        "pt": {
          "term": "Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent",
          "lang": "en"
        },
        "id": "766045006"
      }
    },
    {
      "term": "A subgroup of therapy-related myeloid neoplasms (t-MN), associated with a treatment of an unrelated neoplastic or autoimmune disease with cytotoxic agents, like cyclophosphamid, platins, melphalan and others. The neoplastic cells typically harbour unbalanced aberrations of chromosomes 5 and 7 (monosomy 5/del(5q) and monosomy 7/del(7q)) or a complex karyotype. It usually presents with multilineage dysplasia and cytopenias 5-10 years after exposure, with symptoms related to the degree of bone marrow failure and the corresponding cytopenia (fatigue, bleeding and bruising, recurrent infections, bone pain).",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "766045006",
        "active": true,
        "definitionStatus": "FULLY_DEFINED",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent (disorder)",
          "lang": "en"
        },
        "pt": {
          "term": "Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent",
          "lang": "en"
        },
        "id": "766045006"
      }
    },
    {
      "term": "Nephrotic syndrome with often-early onset defined by severe proteinuria with low serum albumin and possible edema. This disease is rare but severe as it usually progresses to end-stage renal failure. Mutations in the NPHS2 gene (chromosome 1q25-q31 and encoding podocine) have been found to be involved in autosomal recessive forms of the disease. Mutations in the podocine gene have also been detected in later-onset forms and in apparently sporadic forms. Mutations in the ACTN4 gene, coding for alpha-actinine 4, have been reported in autosomal dominant forms. Familial forms of idiopathic steroid-resistant nephrotic syndrome do not respond to any treatment with steroids or immunosuppressive drugs and the disease progress to terminal renal failure.",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "718141008",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Genetic steroid-resistant nephrotic syndrome (disorder)",
          "lang": "en"
        },
        "pt": {
          "term": "Genetic steroid-resistant nephrotic syndrome",
          "lang": "en"
        },
        "id": "718141008"
      }
    },
    {
      "term": "Nephrotic syndrome with often-early onset defined by severe proteinuria with low serum albumin and possible oedema. This disease is rare but severe as it usually progresses to end-stage renal failure. Mutations in the NPHS2 gene (chromosome 1q25-q31 and encoding podocine) have been found to be involved in autosomal recessive forms of the disease. Mutations in the podocine gene have also been detected in later-onset forms and in apparently sporadic forms. Mutations in the ACTN4 gene, coding for alpha-actinine 4, have been reported in autosomal dominant forms. Familial forms of idiopathic steroid-resistant nephrotic syndrome do not respond to any treatment with steroids or immunosuppressive drugs and the disease progress to terminal renal failure.",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "718141008",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Genetic steroid-resistant nephrotic syndrome (disorder)",
          "lang": "en"
        },
        "pt": {
          "term": "Genetic steroid-resistant nephrotic syndrome",
          "lang": "en"
        },
        "id": "718141008"
      }
    }
  ]
}